Save the Date
This free, virtual event, hosted by OncLive, is set for Tues., April 19, from 6:30 to 8 pm.
Lung Cancer Discussion Topics
• Latest Frontline Immunotherapy in NSCLC
• Current Management of SCLC
• Adjuvant Therapy for Surgically Resected NSCLC
• Surgical Perspectives on Neoadjuvant Therapy for NSCLC
Management of earlier-stage disease is increasingly important with recent approvals in the adjuvant (IMpower010, ADAURA) and neoadjuvant (Checkmate 816) space.
Bring Your Questions on Lung Cancer
Time will be allotted for Q&A throughout the program.